<DOC>
	<DOC>NCT01375361</DOC>
	<brief_summary>This is a randomized trial of the use of Albuterol in the setting of acute decompensated Congestive Heart Failure with radiographic evidence of Cardiogenic Pulmonary Edema.</brief_summary>
	<brief_title>Nebulized Albuterol for Congestive Heart Failure Exacerbation</brief_title>
	<detailed_description>The objective is to carry out a randomized blinded placebo-controlled trial of inhaled Albuterol as an early therapy for patients with decompensated Congestive Heart Failure. Compared to placebo, inhaled Albuterol will improve oxygenation and decrease the need for non-invasive ventilation in patients with Cardiogenic Pulmonary Edema.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>age 1865 with shortness of breath and history of CHF pulmonary edema on chest xr pregnancy clinical or ekg changes to suggest acute coronary syndrome history of copd or asthma history of albuterol on medication list</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>albuterol</keyword>
</DOC>